ArticleDer Unfallchirurg2010
[Thromboembolism prophylaxis in trauma surgery: S3 guidelines and significance of the amendment for trauma surgeons].
Article in Der Unfallchirurg, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- [New oral anticoagulants from the perspective of trauma surgery].Der Unfallchirurg · 2010Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prevention of venous thromboembolism has become an integral component of trauma surgery treatment and consists of physical and pharmacological measures. The indications and choice of prophylaxis modalities depend on the patient's individual risk profile which is determined by the combination of exposing and predisposing risk factors. The exposing risk is characterized by the type and extent of surgery or trauma, whereas the predisposing risk relates to patient inherent risk factors. This has also been considered in the compilation of the guidelines. This review summarizes the recommendations of the German S3 guidelines relating to trauma surgery and also discusses the amendment referring to the registration of the new oral anticoagulants rivaroxaban and dabigatran etexilate. The availability of these new compounds increases the spectrum of prophylaxis modalities thereby creating a need for new information in trauma surgery.
Indexed as
Identifiers
21069506What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.